Trial volunteers are in short supply. Without them, new treatments don't get to market. Can the industry convince participants that they aren't just medical guinea pigs?
Jun 1, 2006
By:
Kathleen Drennan
Three friends are talking over lunch. The first person declares, "I'm donating blood," to which his friends reply, "That's good." The second says, "I'm donating an organ." They all agree that it's great. When the third person announces, "I'm participating in a clinical drug trial," his statement is met with silence, confusion, then skepticism.
|
PharmExec Blog
Follow Us
RSS
Bookstore
